Document Detail

Calcium channel blockers suppress daily variations of blood pressure in hypertensive patients with end-stage renal diseases.
MedLine Citation:
PMID:  24625333     Owner:  NLM     Status:  In-Data-Review    
Abstract Hypertension is a well-known cardiovascular risk. Patients with end-stage renal diseases frequently suffer hypertension. Furthermore, daily variations of blood pressure are relatively large in patients treated with hemodialysis, partly due to ultrafiltration. Twenty hypertensive patients with end-stage renal diseases whose blood pressure was controlled by a single antihypertensive agent, either angiotensin receptor antagonist (ARB) or calcium channel blocker (CCB), were enrolled into the study. Home blood pressure measurements were also performed. Average systolic and diastolic blood pressures were similar between two agents. However, variations of systolic blood pressure during ARB treatment were greater than those of CCB, and maximal differences in daily systolic blood pressure during treatment with ARB (19 ± 7 mmHg) were greater than those with CCB (14 ± 6 mmHg, p < 0.01). Systolic blood pressure measured after hemodialysis under ARB therapy (110 ± 6 mmHg) was lower than that of CCB (118 ± 6 mmHg, p < 0.05). Daily variations of diastolic blood pressure were similar between ARB and CCB periods. Our results indicate that variations of systolic blood pressure during ARB treatment are larger than CCB, and suggest that CCB is useful to obtain the better quality of blood pressure control, improving blood pressure stability by preventing substantial drops in blood pressure in hypertensive patients with end-stage renal diseases.
Tsuneo Takenaka; Keita Sueyoshi; Jonde Arai; Yusuke Watanabe; Hiroshi Takane; Yoichi Ohno; Hiromichi Suzuki
Related Documents :
6715833 - A new high-pressure injection injury of the hand.
2224903 - High-pressure glycosylations of unreactive alcohols and the formation of n-glycosyl col...
20018583 - The use of dry powder inhaler devices by elderly patients suffering from chronic obstru...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical and experimental hypertension (New York, N.Y. : 1993)     Volume:  36     ISSN:  1525-6006     ISO Abbreviation:  Clin. Exp. Hypertens.     Publication Date:  2014  
Date Detail:
Created Date:  2014-03-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9305929     Medline TA:  Clin Exp Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  78-82     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Biological applications of LbL multilayer capsules: From drug delivery to sensing.
Next Document:  The velocity of home blood pressure reduction in response to low-dose eplerenone combined with other...